z-logo
Premium
Clinical predictors of antitachycardia pacing response in implantable cardioverter defibrillator patients
Author(s) -
Harrison Joshua W.,
Manola Akrivi,
Kalluri Lakshmi K.,
Duvall W. Lane,
Giedrimiene Dalia,
Kluger Jeffrey W.
Publication year - 2019
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/pace.13760
Subject(s) - medicine , cardiology , amiodarone , ischemic cardiomyopathy , ventricular tachycardia , qrs complex , implantable cardioverter defibrillator , tachycardia , ejection fraction , cardiac resynchronization therapy , cardiomyopathy , heart failure , atrial fibrillation
Background Antitachycardia pacing (ATP) provides safe and painless termination of reentrant ventricular arrhythmias in patients with implantable cardioverter defibrillator (ICDs), improving their quality of life. Established predictors of ATP responsiveness are not well known; only longer ventricular tachycardia (VT) cycle length and higher ejection fraction have been found to predict ATP success. Objective To investigate clinical and ECG predictors of ATP response in ICD patients with monomorphic VT. Methods The ICD clinic database was searched for monomorphic VT events requiring ICD therapy in patients with ischemic or non‐ischemic cardiomyopathy. Each patient's first ICD encounter for VT was assessed. Patient demographics, clinical characteristics, VT rate, and ATP responsiveness (always, sometimes, and never successful) were recorded. An ECG was analyzed for QRS morphology and duration. Data was assessed for predictors of ATP responsiveness. Results In 527 patients, characteristics associated with always successful ATP included ACE‐I/ARB therapy and slower VT rate (never successful ATP 197 ± 28 bpm, sometimes successful ATP 190 ± 27 bpm, always successful ATP 183 ± 22 bpm, P  < .0001). Secondary prevention indication, amiodarone therapy, and longer QRS duration were associated with ATP failure. After multivariate analysis, only faster VT rate and amiodarone therapy were predictive of ATP failure. Conclusions Neither QRS morphology nor duration was predictive of ATP success. Slower VT rate was predictive of repeated ATP responsiveness. Amiodarone therapy, which is known to increase VT cycle length, interestingly was associated with ATP failure for unclear reasons. More individualized and possibly more aggressive ATP programming may be warranted in patients on amiodarone.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here